浙江东方：子公司发起设基金，控股股东提供借款额度

Core Viewpoint - Zhejiang Oriental announced the approval of two proposals by its tenth board of directors, focusing on the establishment of a new fund and a loan provision for operational needs [1] Group 1: Fund Establishment - The company approved the establishment of the "Oriental Zhe Pharmaceutical Zhongying Binjiang Medical Fund," with a fundraising target not exceeding 500 million yuan [1] - Oriental Chanin, as the fund manager, and its designated subsidiaries will contribute 121.2 million yuan, accounting for 24.04% of the total fund [1] - Zhe Pharmaceutical Group will contribute 29.8 million yuan, representing 5.96% of the fund [1] Group 2: Loan Provision - The company agreed to provide a loan limit of 1.3 billion yuan from its controlling shareholder to its subsidiary Guojin Financial Leasing for daily operations and debt replacement [1] - The loan has a validity period until July 20, 2026, with an annual interest rate not exceeding 3.15% [1] - The loan term will not exceed three years, and this proposal requires approval from the shareholders' meeting [1]